American Association for Cancer Research
10780432ccr210325-sup-259670_2_supp_7149638_qts6cs.docx (15.91 kB)

Table S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

Download (15.91 kB)
journal contribution
posted on 2023-03-31, 22:45 authored by Yalai Bai, Kimberly Cole, Sandra Martinez-Morilla, Fahad Shabbir Ahmed, Jon Zugazagoitia, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Nimeus, Johan Hartman, Balazs Acs, David L. Rimm

Areas of assessment


Career Development Program

National Health Service

Swedish Cancer Society

Senior Investigator Award

Berta Kamprad Foundation



Although tumor-infiltrating lymphocytes (TIL) assessment has been acknowledged to have both prognostic and predictive importance in triple-negative breast cancer (TNBC), it is subject to inter and intraobserver variability that has prevented widespread adoption. Here we constructed a machine-learning based breast cancer TIL scoring approach and validated its prognostic potential in multiple TNBC cohorts. Using the QuPath open-source software, we built a neural-network classifier for tumor cells, lymphocytes, fibroblasts, and “other” cells on hematoxylin–eosin (H&E)–stained sections. We analyzed the classifier-derived TIL measurements with five unique constructed TIL variables. A retrospective collection of 171 TNBC cases was used as the discovery set to identify the optimal association of machine-read TIL variables with patient outcome. For validation, we evaluated a retrospective collection of 749 TNBC patients comprised of four independent validation subsets. We found that all five machine TIL variables had significant prognostic association with outcomes (P ≤ 0.01 for all comparisons) but showed cell-specific variation in validation sets. Cox regression analysis demonstrated that all five TIL variables were independently associated with improved overall survival after adjusting for clinicopathologic factors including stage, age, and histologic grade (P ≤ 0.0003 for all analyses). Neural net-driven cell classifier-defined TIL variables were robust and independent prognostic factors in several independent validation cohorts of TNBC patients. These objective, open-source TIL variables are freely available to download and can now be considered for testing in a prospective setting to assess clinical utility.See related commentary by Symmans, p. 5446

Usage metrics

    Clinical Cancer Research



    Ref. manager